San Diego-based Ambrx, a biopharmaceuticals company developing antibodies and proteins, including a Phase 2b growth hormone compound, said today that it has named Lawson Macartney as President and CEO of the company. Macartney also joins the company's board of directors. Macartney was previously at Shire, GlaxoSmithKline PLC, Astra Pharmaceuticals and Ribozyme Pharmaceuticals.
Top NewsMonday, January 7, 2013
Ambryx Names New CEO